Akums Drugs and Pharmaceuticals shatters records with 52% adj PAT growth – new facilities announced
Akums Drugs and Pharmaceuticals Limited, a leading name in the Indian pharmaceutical industry, has announced its unaudited financial results for the first quarter of FY25, ... Read More
Rajoo Engineers Q1 FY25 financials soar as company unveils massive facility expansion and cutting-edge technology
Rajoo Engineers Limited has unveiled impressive financial results for the first quarter ended June 30, 2024, showcasing significant growth and strategic advancements. The company's latest ... Read More
Coforge hits new highs in revenue and profitability for Q1 FY25: Strong outlook ahead
Coforge Limited, listed on the National Stock Exchange of India (NSE) under the ticker COFORGE, reported a substantial increase in its financial performance for the ... Read More
Adani Portfolio achieves record financial performance in FY24 with 45% EBITDA growth
Adani Portfolio has reported a stellar financial performance for the fiscal year 2024, achieving an unprecedented EBITDA growth of 45%, amounting to USD 10 billion. ... Read More
Glenmark Pharmaceuticals reports Q4 FY2023-24 revenue of Rs 30.63bn
Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending March 31, 2024, showcasing a solid performance ... Read More